CEACAM1 and neoplasm: Notably, bivariant, dual marker density plots also showed that a discrete collection of CEACAM1+PD1+ cells could be detected in all manually gated subsets of CD4+ T cells within the treatment-resistant PBMC and tumor samples (Fig. 6l).